BloomingdaleLMBloomingdaleEC. Childhood identification and prophylaxis of antisocial personality disorder. J Forensic Sc1988; 33: 187–199.
2.
BiedermanJNewcornJSprichS. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry1991; 148: 564–577.
3.
StockardJJIraguiVJ. Clinically useful applications of evoked potentials in adult neurology. J Clin Neurophysiol1984; 1: 159–202.
LahatEAvitalE. BAEP studies in children with Attention Deficit Disorder. Dev Med Child Neurol1995; 37: 119–123.
6.
PictonTW. The P300 wave of the human eventrelated potential. J Clin Neurophysiology1992; 9: 456–479.
7.
KlormanRSalzmanLFPassHL. Effects of methylphenidate on hyperactive children's evoked responses during passive and active attention. Psychophysiology1979; 16: 23–29.
8.
HolcombPJAckermanPTDykmanRA. Cognitive event-related brain potentials in children with attention and reading deficits. Psychophysiology1985; 22: 656–667.
RobaeyPBretonFDugasM. An event-related potential study of controlled and automatic processes in 6–8 year-old boys with attention deficit hyperactivity disorderElectroencephalogr Clin Neurophysiol1992; 85: 330–340.
11.
NunezPLPilgreenKL. The Spline-Laplacian in clinical neurophysiology, a method to improve spatial EEG resolution. J Clin Neurophysiology1991; 8: 397–413.
12.
WilsonMALanguisML. A topographic study of differences in the P300 between introverts and extraverts. Brain Topography1990. 2: 269–274.
13.
FauxSFTorelloMMcCarleyR. P300 in schizophrenia: Confirmation and statistical validation of temporal region deficit in P300 topography. Biol Psychiat1988; 23: 776–790.
14.
BensonDF. The role of frontal dysfunction in Attention Deficit Hyperactivity Disorder. J Child Neurology1991; 6: S9–S12.
15.
LouHCHenriksenLBruhnP. Focal cerebral hypoperfusion in children with dysphasia and/or attention deficit disorder. Arch Neurology1984; 41: 825–829.
16.
SatterfieldJHSchellAMNicholasTW. Ontogeny of selective attention effects on event-related potentials in attention-deficit hyperactivity disorder and normal boys. Biol Psychiatry1990; 28: 879–903.
17.
LevyF. The dopamine theory of attention deficit hyperactivity disorder (ADD). Aust NZ J Psychiatry1991; 25: 277–283.
18.
QuinnPORapoportJL. One-year follow-up of hyperactive boys treated with imipramine or methylphenidate. Am J Psychiatry1975; 132: 241–245.
19.
McBrideMC. An individual double-blind crossover trial for assessing methylphenidate responses in children with Attention Deficit Disorder. J Pediatrics1988; 113: 137–145.
20.
GualtieriCTEvansRW. Motor performance in hyperactive children treated with imipramine. Percept Mot Skills1988; 66: 763–769.
21.
StevensonRDWolraichML. Stimulant medication therapy in the treatment of children with attention deficit hyperactivity disorder. Ped Clin North America1989; 36: 1183–1197.
22.
SatterfieldJHSchellAM. Childhood brain function differences in delinquent and non-delinquent hyperactive boysElectroencephalogr Clin Neurophysiol1987; 67: 531–536.
23.
SuffinSCEmoryWH. Neurometric subgroups in attentional and affective disorders and their association with pharmacotherapeutic outcome. Clin Electroencephalogr1995; 26: 76–83.
24.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed rev. Washington, DC. 1987.
CaseR. The role of the frontal lobes in the regulation of cognitive development. Brain-Cogn1992; 20: 51–73.
34.
SangalRBSangalJM. P300 Latency: Abnormal in sleep apnea with somnolence and idiopathic hypersomnia, but normal in narcolepsy. Clin Electroencephalogr1995; 26: 146–153.